Seroprevalence of Hepatitis C, Hepatitis B, and HIV Infections among Hemodialysis Patients in Al-Diwanyah, Iraq
DOI:
https://doi.org/10.46966/msjar.v6i4.340Keywords:
Hepatitis C virus, Hepatitis B virus, HIV, Hemodialysis, End stage renal disease.Abstract
Background: The blood -borne infections such as Hepatitis B (HBV), Hepatitis C (HCV), and Human immunodeficiency virus (HIV) are the most important and significant causes of serious chronic illnesses in patients with end stage of renal disease that undergo long-term hemodialysis sessions. The frequency of hepatitis viral infections amongst hemodialysis patients is relatively elevated and differs among different countries and also among dialysis centers into the same country. Method: During 2024, a cross-sectional study was achieved in Al-Diwanyah province in Iraq, among 275 HD patients from hemodialysis centers of Al-Diwanyah teaching hospital. All positive cases were screened for Hepatitis B surface Ag (HBs-Ag), Hepatitis C virus Ab (HCVAb) and HIV antibody (HIV-Ab), using specific enzyme-linked immunoassay (Elisa technique). Result: The total number of patients attended for receiving hemodialysis services throughout the study period was 275. Only 40/275(14.5%) was positive for hepatitis infections (HBV,HCV or both). Among these, only 7/275(2.5%) patients appeared positive for HBV, 25/275(9%) patients appeared positive for HCV, and 8/275(2.9%) were positive for co-infections of HCV and HBV, while, there was no infection with HIV. Mean of the age of infected patients in present study appeared 39.3 years. The infections were concentrated in males with 29/40(72.5%) more than females 11/40(27.5%). While, infections were concentrated in rural areas with 27/40(67.5%) more than urban areas 13/40(37.5%). Mean of the duration of dialysis courses for positive cases was 3.6 hours and mean of dialysis intervals was three time a week. Conclusion: Adherence to health and preventive standards for kidney dialysis centers to prevent the spread of viral infections among patients is an essential factor in protecting them from the risks of such infections and its long-term complications, which are considered life threatening in the foreseeable future.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Mohammed Abdulkadhim Sayah , Abbas Ghafil Abbas
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
